Transforming How the World Makes Chemicals
Innovative Bio-Based Specialty Chemicals for a Healthier Future
At DMC Biotechnologies, we are revolutionizing the specialty chemical industry by offering sustainable, bio-based ingredients that meet the highest standards of safety, health, and environmental responsibility.
Our pioneering Dynamic Metabolic Control™ technology delivers reliable, cost-effective, and scalable products to meet the growing demands of the market.
OUR PRODUCTS
Our first generation of products showcases the power of our technology platform to produce sustainable, affordable chemicals for a wide range of markets. With a strong pipeline of innovative products already in place and more in development, we are actively transforming the landscape of sustainable chemical production.
DIETARY SUPPLEMENTS & NUTRACEUTICALS
COSMETIC ACTIVES
BIO-BASED CHEMICALS & MONOMERS
COLLABORATING WITH DMC
Go from concept to commercial faster with our standardized, scalable, and proven technology platform that’s Made to Scale™.
DEVELOPMENT
EFFICIENCY
Go from concept to commercial faster with our standardized, scalable, and proven technology platform.
SUSTAINABLE
PRODUCTION
Our L-alanine production in Europe will reduce CO2 emissions by over 90%, compared to imported L-alanine. That’s equivalent to removing more than 60,000 cars from the road, annually.
SUPPLY CHAIN
SECURITY
Cost-competitive, local production using agricultural feedstocks enables our customers to diversify their supply chain, making them more resilient to the next global shift.
PARTNER WITH DMC ON YOUR NEXT PRODUCT
DMC’s innovative technology and metabolic engineering expertise enables a broad range of bio-based chemicals to be commercialized rapidly and produced cost-effectively through precision fermentation.
RECENT NEWS
DMC Welcomes Rusty Pittman, VP of Business Development
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Co-Founders Matt and Mike Finalists in EY Entrepreneur Of The Year 2020
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
Doug Cameron Joins DMC Board of Directors
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Completes Successful Pilot of L-alanine
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
INVESTORS
